Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31953) 31953
Newsletter (1668) 1668
Book Chapter (467) 467
Newspaper Article (439) 439
Magazine Article (127) 127
Book / eBook (57) 57
Dissertation (37) 37
Publication (24) 24
Web Resource (12) 12
Conference Proceeding (9) 9
Reference (9) 9
Trade Publication Article (8) 8
Transcript (5) 5
Journal / eJournal (2) 2
Book Review (1) 1
Government Document (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (22019) 22019
humans (21868) 21868
life sciences & biomedicine (21006) 21006
male (15772) 15772
diabetes (13888) 13888
female (13458) 13458
middle aged (10709) 10709
adult (8181) 8181
endocrinology & metabolism (7843) 7843
biological and medical sciences (7606) 7606
medical sciences (7438) 7438
aged (7062) 7062
risk factors (6356) 6356
animals (6251) 6251
diabetes mellitus (6200) 6200
diabetic nephropathies (6163) 6163
diabetic nephropathy (5729) 5729
endocrinopathies (5347) 5347
type 2 diabetes (5318) 5318
endocrine pancreas. apud cells (5269) 5269
diabetes. impaired glucose tolerance (5230) 5230
diabetics (5156) 5156
diabetic retinopathy (4423) 4423
diabetes mellitus, type 2 - complications (4323) 4323
research (4228) 4228
diabetic nephropathies - physiopathology (3564) 3564
care and treatment (3551) 3551
blood pressure (3483) 3483
urology & nephrology (3332) 3332
kidney diseases (3137) 3137
analysis (3130) 3130
glucose (3066) 3066
hypertension (2957) 2957
rats (2872) 2872
health aspects (2733) 2733
diabetic nephropathies - blood (2724) 2724
associated diseases and complications (2627) 2627
blood glucose - metabolism (2555) 2555
kidneys (2551) 2551
diabetic nephropathies - drug therapy (2539) 2539
etiopathogenesis. screening. investigations. target tissue resistance (2522) 2522
medicine & public health (2461) 2461
diabetes mellitus, type 1 - complications (2437) 2437
diabetes mellitus, type 2 - blood (2436) 2436
diabetic nephropathies - metabolism (2390) 2390
type 1 diabetes (2297) 2297
diabetic nephropathies - pathology (2291) 2291
glomerular filtration rate (2218) 2218
abridged index medicus (2209) 2209
medical research (2201) 2201
diabetic nephropathies - etiology (2194) 2194
development and progression (2145) 2145
nephropathy (2140) 2140
internal medicine (2117) 2117
hyperglycemia (2088) 2088
oxidative stress (2055) 2055
diabetes mellitus, type 2 - physiopathology (2036) 2036
adolescent (2027) 2027
studies (1961) 1961
insulin (1950) 1950
cardiovascular disease (1943) 1943
complications and side effects (1914) 1914
medicine (1900) 1900
disease progression (1890) 1890
albuminuria (1879) 1879
diabetic nephropathies - complications (1867) 1867
diabetic nephropathies - prevention & control (1858) 1858
mice (1858) 1858
proteins (1856) 1856
research article (1852) 1852
general & internal medicine (1820) 1820
medicine, experimental (1801) 1801
mortality (1800) 1800
medicine, general & internal (1799) 1799
diabetes mellitus, type 2 - drug therapy (1780) 1780
rodents (1778) 1778
time factors (1761) 1761
diabetes mellitus, type 1 - physiopathology (1698) 1698
diabetes mellitus, type 1 - blood (1690) 1690
patients (1684) 1684
cardiovascular system & cardiology (1674) 1674
physiological aspects (1669) 1669
diabetic nephropathies - epidemiology (1635) 1635
cross-sectional studies (1611) 1611
glycated hemoglobin a - analysis (1601) 1601
follow-up studies (1598) 1598
treatment outcome (1584) 1584
metabolic diseases (1553) 1553
nephrology (1539) 1539
inflammation (1520) 1520
medicine, research & experimental (1517) 1517
research & experimental medicine (1516) 1516
biomarkers - blood (1505) 1505
chronic kidney failure (1460) 1460
diabetic nephropathies - therapy (1458) 1458
diabetes therapy (1454) 1454
pharmacology & pharmacy (1451) 1451
prospective studies (1435) 1435
diabetic nephropathies - diagnosis (1433) 1433
aged, 80 and over (1432) 1432
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (16) 16
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Baycrest Hospital - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (33643) 33643
German (355) 355
Japanese (332) 332
Chinese (226) 226
French (190) 190
Spanish (151) 151
Russian (148) 148
Portuguese (88) 88
Polish (77) 77
Italian (51) 51
Czech (37) 37
Korean (24) 24
Hungarian (22) 22
Bulgarian (18) 18
Slovak (14) 14
Danish (13) 13
Turkish (11) 11
Croatian (10) 10
Romanian (10) 10
Ukrainian (10) 10
Dutch (9) 9
Persian (9) 9
Serbian (8) 8
Swedish (6) 6
Hebrew (5) 5
Norwegian (5) 5
Bosnian (4) 4
Finnish (2) 2
Indonesian (2) 2
Georgian (1) 1
Greek (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Effect of finerenone on albuminuria in patients with diabetic nephropathy a randomized clinical trial
by Bakris, George L and Agarwal, Rajiv and Chan, Juliana C and Cooper, Mark E and Gansevoort, Ron T and Haller, Hermann and Remuzzi, Giuseppe and Rossing, Peter and Schmieder, Roland E and Nowack, Christina and Kolkhof, Peter and Joseph, Amer and Pieper, Alexander and Kimmeskamp-Kirschbaum, Nina and Ruilope, Luis M and Mineralocorticoid Receptor and Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Naphthyridines - adverse effects | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Incidence | Dose-Response Relationship, Drug | Diabetes Mellitus, Type 2 - ethnology | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hyperkalemia - epidemiology | Female | Blood Pressure - drug effects | Diabetes Mellitus, Type 2 - complications | Diabetic Nephropathies - urine | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Diabetes Mellitus, Type 2 - urine | Diabetic Nephropathies - ethnology | Creatinine - urine | Mineralocorticoid Receptor Antagonists - therapeutic use | Analysis of Variance | Albuminuria - drug therapy | Hyperkalemia - chemically induced | Least-Squares Analysis | Potassium - blood | Aged | Angiotensin Receptor Antagonists - therapeutic use | Naphthyridines - administration & dosage | Proteins | Clinical trials | Side effects | Diabetes | Antagonist drugs | ACE inhibitors
Journal Article
Details down arrow
2. Full Text Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy Results of the ADVANCE study
by Morton, Jamie and Zoungas, Sophia and Li, Qiang and Patel, Anushka A and Chalmers, John and Woodward, Mark and Celermajer, David S and Beulens, Joline W. J and Stolk, Ronald P and Glasziou, Paul and Ng, Martin K. C and ADVANCE Collaborative Grp and ADVANCE Collaborative Group and on behalf of the ADVANCE Collaborative Group
Diabetes care, ISSN 0149-5992, 11/2012, Volume 35, Issue 11, pp. 2201 - 2206
RENAL DYSFUNCTION | PLASMA-LIPIDS | MICROALBUMINURIA | DISEASE | RANDOMIZED CONTROLLED-TRIAL | MELLITUS | COMMUNITIES | UMCG Approved | ATHEROSCLEROSIS RISK | BLOOD-PRESSURE | PROGRESSION | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Associated diseases and complications | Disorders of blood lipids. Hyperlipoproteinemia | Diabetic Nephropathies - etiology | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Diabetic Nephropathies - blood | Diabetic Retinopathy - blood | Diabetes Mellitus, Type 2 - blood | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Diabetic Retinopathy - etiology | Diabetes Mellitus, Type 2 - complications | Diabetic retinopathy | Diabetics | Blood cholesterol | Atherosclerosis | Diabetic nephropathies | Development and progression | Diabetes | Research | Risk factors | Diet | Risk assessment | Blood pressure | Kidney diseases | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
by Perkovic, Vlado and Jardine, Meg J and Neal, Bruce and Bompoint, Severine and Heerspink, Hiddo J.L and Charytan, David M and Edwards, Robert and Agarwal, Rajiv and Bakris, George and Bull, Scott and Cannon, Christopher P and Capuano, George and Chu, Pei-Ling and de Zeeuw, Dick and Greene, Tom and Levin, Adeera and Pollock, Carol and Wheeler, David C and Yavin, Yshai and Zhang, Hong and Zinman, Bernard and Meininger, Gary and Brenner, Barry M and Mahaffey, Kenneth W and CREDENCE Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 24, pp. 2295 - 2306
KIDNEY-DISEASE | EMPAGLIFLOZIN | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Glomerular Filtration Rate | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Canagliflozin - adverse effects | Diabetic Nephropathies - complications | Diabetes Mellitus, Type 2 - blood | Kidney Failure, Chronic - epidemiology | Kidney Failure, Chronic - prevention & control | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetes Mellitus, Type 2 - complications | Myocardial infarction | End-stage renal disease | Laboratories | Hemodialysis | Clinical trials | Immunosuppressive agents | Clinical outcomes | Renin | Amputation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Creatinine | Cerebral infarction | Enzymes | Kidneys | Diabetes mellitus | Glomerular filtration rate | Nephropathy | Sodium | Collaboration | Angiotensin | Renal failure | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: The TODAY clinical trial
by Lynch, Jane and El Ghormli, Laure and Fisher, Lynda and Gidding, Samuel S and Laffel, Lori and Libman, Ingrid and Pyle, Laura and Tamborlane, William V and Tollefsen, Sherida and Weinstock, Ruth S and Zeitler, Phil and TODAY Study Grp and TODAY Study Group
Diabetes care, ISSN 0149-5992, 06/2013, Volume 36, Issue 6, pp. 1735 - 1741
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Albuminuria - epidemiology | Body Mass Index | Hypertension | Hypoglycemic Agents - therapeutic use | Diabetic Nephropathies - metabolism | Glycated Hemoglobin A - metabolism | Humans | Male | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 2 - epidemiology | Diabetes Mellitus, Type 2 - physiopathology | Adolescent | Female | Albuminuria - metabolism | Diabetic Nephropathies - epidemiology | Blood Glucose - metabolism | Child | Type 2 diabetes | Research | Analysis | Diabetic nephropathies | Health sciences | Hospitals | Algorithms | Colleges & universities | Clinical trials | Teenagers | Diabetes | Kidney diseases | Native North Americans | Age | Children & youth | Food | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Update on Diabetic Nephropathy: Core Curriculum 2018
by Umanath, Kausik and Lewis, Julia B
American journal of kidney diseases, ISSN 0272-6386, 06/2018, Volume 71, Issue 6, pp. 884 - 895
blood pressure | angiotensin receptor blocker (ARB) | review | RAS blockade | hemoglobin A1c (HbA1c) | angiotensin-converting enzyme inhibitor (ACEi) | end-stage kidney disease (ESKD) | renin-angiotensin system (RAS) | diabetes | hypertension | diabetic nephropathy | Diabetic kidney disease | HbA | ) | hemoglobin A | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Nephropathy in Diabetes
by Molitch, Mark E and DeFronzo, Ralph A and Franz, Marion J and Keane, William F and Mogensen, Carl Erik and Parving, Hans-Henrik and Steffes, Michael W and American Diabetes Association
Diabetes care, ISSN 0149-5992, 01/2004, Volume 27, Issue suppl 1, pp. s79 - S83
Diet, Protein-Restricted | Diabetic Nephropathies - physiopathology | Albuminuria - diagnosis | Humans | Mass Screening - standards | Antihypertensive Agents - therapeutic use | Blood Glucose - metabolism | Diabetic Nephropathies - diagnosis | Diabetic Nephropathies - prevention & control | Causes of | Development and progression | Care and treatment | Diagnosis | Research | Diabetic nephropathies | Urine | Kidneys | Diabetes | Hemodialysis | Medical treatment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Obstructive sleep apnea and diabetic nephropathy: A cohort study
by Tahrani, Abd A and Ali, Asad and Raymond, Neil T and Begum, Safia and Dubb, Kiran and Altaf, Quratulain and Piya, Milan K and Barnett, Anthony H and Stevens, Martin J
Diabetes care, ISSN 0149-5992, 11/2013, Volume 36, Issue 11, pp. 3718 - 3725
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Diabetes. Impaired glucose tolerance | Respiratory system : syndromes and miscellaneous diseases | Biological and medical sciences | Endocrinopathies | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Associated diseases and complications | Pneumology | Albuminuria - epidemiology | Prevalence | Albuminuria - etiology | Albuminuria - blood | Humans | Middle Aged | Male | Biomarkers - blood | Renal Insufficiency, Chronic - complications | Diabetes Mellitus, Type 2 - blood | Kidney Failure, Chronic - complications | Adult | Diabetes Mellitus, Type 2 - embryology | Female | Aged | Diabetic Nephropathies - epidemiology | Sleep Apnea, Obstructive - epidemiology | Diabetes Mellitus, Type 2 - complications | Cohort Studies | Type 2 diabetes | Sleep apnea syndromes | Research | Chronic kidney failure | Cholesterol | Diabetic nephropathies | Oxidative stress | Diabetic neuropathy | Sleep apnea | Kidney diseases | Diabetes | Medical treatment | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Diabetic nephropathy: Diagnosis and treatment
by Fineberg, Daniel and Jandeleit-Dahm, Karin A. M and Cooper, Mark E
Nature reviews. Endocrinology, ISSN 1759-5029, 12/2013, Volume 9, Issue 12, pp. 713 - 723
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Diabetic Nephropathies - drug therapy | Renin-Angiotensin System - drug effects | Blood Pressure - drug effects | Antihypertensive Agents - therapeutic use | Diabetic Nephropathies - diagnosis | Humans | Care and treatment | Diagnosis | Research | Diabetic nephropathies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: An inception cohort study
by Hovind, Peter and Rossing, Peter and Tarnow, Lise and Johnson, Richard J and Parving, Hans-Henrik
Diabetes (New York, N.Y.), ISSN 0012-1797, 07/2009, Volume 58, Issue 7, pp. 1668 - 1671
Diabetes. Impaired glucose tolerance | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephrology. Urinary tract diseases | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Associated diseases and complications | Albuminuria - epidemiology | Blood Pressure | Predictive Value of Tests | Prospective Studies | Follow-Up Studies | Humans | Risk Factors | Male | Diabetes Mellitus, Type 1 - complications | Diabetic Nephropathies - blood | Incidence | Young Adult | Time Factors | Adolescent | Adult | Female | Diabetic Nephropathies - epidemiology | Uric Acid - blood | Cohort Studies | Complications and side effects | Care and treatment | Type 1 diabetes | Diabetic nephropathies | Diagnosis | Research | Uric acid | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights